Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25717256)

  • 1. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of Sema4D expression by tumor-associated macrophages: Significance in gastric carcinoma.
    Li H; Wang JS; Mu LJ; Shan KS; Li LP; Zhou YB
    World J Gastroenterol; 2018 Feb; 24(5):593-601. PubMed ID: 29434448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.
    Fillies T; Werkmeister R; van Diest PJ; Brandt B; Joos U; Buerger H
    BMC Cancer; 2005 Jul; 5():84. PubMed ID: 16035955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.
    Wan XB; Fan XJ; Huang PY; Dong D; Zhang Y; Chen MY; Xiang J; Xu J; Liu L; Zhou WH; Lv YC; Wu XY; Hong MH; Liu Q
    Cancer Sci; 2012 Aug; 103(8):1586-94. PubMed ID: 22587416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis.
    Ha YJ; Han DW; Kim JH; Chung SW; Kang EH; Song YW; Lee YJ
    Dis Markers; 2018; 2018():2318386. PubMed ID: 30538782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factor-1α (HIF-1α) as a Factor to Predict the Prognosis of Spinal Chordoma.
    He G; Liu X
    Spine (Phila Pa 1976); 2024 May; 49(9):661-669. PubMed ID: 38251727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
    Diao YQ; Wang J; Zhu XL; Chen J; Zheng Y; Jiang L; Liu YP; Dai RH; Yan YW
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1150-1155. PubMed ID: 37990460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of plasma soluble Sema4D in patients with heart failure.
    Lu Q; Dong N; Wang Q; Yi W; Wang Y; Zhang S; Gu H; Zhao X; Tang X; Jin B; Wu Q; Brass LF; Zhu L
    PLoS One; 2013; 8(5):e64265. PubMed ID: 23741311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases.
    Zauderer M; Evans EE
    Clin Transl Med; 2023 Feb; 13(2):e1169. PubMed ID: 36710564
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.
    Igbo BT; Jentsch C; Linge A; Plesca I; Kuzay Y; Löck S; Kumaravadivel MS; Doms S; Stolz-Kieslich L; Pollack D; Brückmann S; Tittlbach H; Weitz J; Aust D; Apolle R; Schmitz M; Troost EGC
    Strahlenther Onkol; 2024 May; ():. PubMed ID: 38727811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy.
    Wu JH; Li YN; Chen AQ; Hong CD; Zhang CL; Wang HL; Zhou YF; Li PC; Wang Y; Mao L; Xia YP; He QW; Jin HJ; Yue ZY; Hu B
    EMBO Mol Med; 2020 Feb; 12(2):e10154. PubMed ID: 31943789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway.
    Zhang Z; Zhang D; Wang F; Liu J; Sun Y; Anuchapreeda S; Tima S; Xiao Z; Duangmano S
    PeerJ; 2023; 11():e15172. PubMed ID: 37096066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEMA4D Knockdown Attenuates
    Rezaeepoor M; Rashidi G; Pourjafar M; Mohammadi C; Solgi G; Najafi R
    Biomed Res Int; 2021; 2021():8507373. PubMed ID: 34337054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D.
    Lyu Z; Jin H; Yan Z; Hu K; Jiang H; Peng H; Zhuo H
    Int J Mol Med; 2020 Oct; 46(4):1321-1334. PubMed ID: 32945351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
    Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
    Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
    Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
    J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment.
    Zeng S; Zhang Z; Ye C; Wang J; Jing C; Li L
    Front Oncol; 2023; 13():1171926. PubMed ID: 37287907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γδ T cell costimulatory ligands in antitumor immunity.
    McGraw JM; Witherden DA
    Explor Immunol; 2022; 2(1):79-97. PubMed ID: 35480230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.